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Abstract
Blood pressure variability is associated with macrovascular complications and stroke, but its 
association with the microcirculation in type II diabetes has not been assessed. This study aimed to 
determine the relationship between blood pressure variability indices and retinal arteriolar diameter in 
non-diabetic and type II diabetes participants. Digitized retinal images were analysed to quantify 
arteriolar diameters in 35 non-diabetic (aged 52 ± 11 years; 49% male) and 28 type II diabetes (aged 
61 ± 9 years; 50% male) participants. Blood pressure variability was derived from 24-h ambulatory 
blood pressure. Arteriolar diameter was positively associated with daytime rate of systolic blood 
pressure variation (p = 0.04) among type II diabetes participants and negatively among non-diabetics 
(p = 0.008; interaction p  = 0.001). This finding was maintained after adjusting for age, sex, body mass 
index and mean daytime systolic blood pressure. These findings suggest that the blood pressure 
variability–related mechanisms underlying retinal vascular disease may differ between people with and 
without type II diabetes. 
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Introduction
Quantitative measures of retinal vascular structure, such as vessel diameters, may provide prognostic 
information regarding microvascular complications and risk related to vascular diseases such as type 
II diabetes (T2DM). Retinal microvascular changes have been related to hypertension,1 while changes 
in retinal arteriolar diameters could be an early pathophysiological indicator in T2DM.2 Although 
narrower retinal arteriolar diameters have been found to be associated with high blood pressure (BP),3
possibly indicating vasoconstriction or inward remodelling in response to elevated BP, wider retinal 
arteriolar diameters were found to be associated with T2DM,4 suggesting impaired arteriolar 
autoregulation5 due to compromised myogenic responses. Negative correlations between BP and 
arteriolar diameters have also been observed in T2DM,6 but evidence suggests that these relationships 
may be weaker than in non-diabetic individuals.7
On the other hand, blood pressure variability (BPV) indices, such as the rate of BP variation over time 
(a measure of the speed of BP change), is thought to be an indication of the alterations in 
cardiovascular regulatory mechanisms that could lead to vascular complications irrespective of the 
mean (average) BP level.8 At the same time, increased arterial stiffness and autonomic dysregulation, 
which could both lead to increased BPV, are common complications in T2DM.9,10 Nevertheless, the 
relevance of BPV or mean BP level to retinal arteriolar diameters as derived from 24-h ambulatory BP 
has never been investigated in individuals with T2DM. The aim of this study was to examine the 
relationship between mean BP levels and BPV with arteriolar diameters, in individuals with T2DM. 
We hypothesized that BPV indices may play a role in retinal vascular structure, as assessed by the 
quantification of arteriolar diameter, in patients with T2DM. 
Methods
Data from this study were derived from a previously published investigation among 80 consecutive 
participants with (n = 40) and without T2DM (n = 40) recruited from the local community.11 This 
current post-hoc, hypothesis-generating analysis was from the 35 non-diabetic and 28 T2DM 
participants where both retinal imaging and 24-h ambulatory BP measurements were available. 
Exclusion criteria included pregnancy, arrhythmia or a clinical history of cardiovascular disease 
(including coronary artery disease, myocardial infarction, heart failure or stroke) or severe pulmonary 
disease. T2DM was self-reported after diagnosis by a doctor. The Human Research Ethics Committee 
of the University of Tasmania approved the study and written informed consent was provided by all 
participants. 
Retinal imaging
Retinal images were recorded using a non-mydriatic retinal camera (Canon, CR-DGi-45NM) and 
digitized to a resolution of 2800–2400 pixels using a LS100 slide scanner (Nikon, Tokyo, Japan). 
Microvascular parameters were measured using a custom written MATLAB program, as described 
previously.12 Good reproducibility of this technique has been previously reported.12 The analysis was 
performed on a series of complete vascular branches, either from one eye or from both eyes in order 
to obtain the required number of vessel segments (8, range: 7–18) and bifurcations (6, range: 3–15). 
Arteriolar diameter was measured in a series of intensity cross-sections normal to the vessel at two-
pixel intervals along the entire length of the vessel segment. At each cross-section, arteriolar diameter 
was measured to subpixel accuracy using a sliding linear regression filter technique as described 
previously12 and the average was calculated for each vessel. 
24-h ambulatory BP and BPV indices
The 24-h ambulatory BP was measured every 20 min during the daytime and every 30 min during the 
night-time (TM-2430; A&D Medical, Sydney, Australia). Participants were asked to continue their 
usual daily activities but to avoid any strenuous activities. Individual measurements with an error code 
or those with a pulse pressure of less than 20 mmHg were excluded from the analysis. BPV was 
expressed separately for the periods of daytime, night-time and 24-h as the rate of BP variation and 
was calculated based on a modified method described by Zakopoulos et al.13 Rate of BP variation was 
further adjusted for the corresponding mean BP levels [(rate of BP variation/mean BP) × 100]. 
Calculations involved plotting the slope for the change between systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) readings against time. Daytime was defined as the period between 
08:00 and 20:00 and night-time as the period between 22:00 and 06:00. The periods from 20:00 to 
22:00 and 06:00 to 08:00 were excluded as they represent the steepest diurnal fall and rise in BP, 
respectively, and, therefore may contribute to BPV measures. BPV was also quantified using the 
coefficient of variation (CV) of the corresponding mean BP level [(standard deviation/mean BP) ×
 100]. 
Blood biochemistry
Venous blood samples were drawn from the antecubital fossa, and analytical biochemistry was 
performed by the Royal Hobart Hospital pathology department using accredited laboratory 
techniques. 
Statistical analysis
Student’s t tests were used to compare retinal and haemodynamic variables between diabetic and non-
diabetic participants. Linear regression analysis was performed to assess the relationship between 
arteriolar diameter and BP measures, further statistical adjustment for possible confounders: age, sex, 
body mass index (BMI; and mean SBP for BPV) was performed by multivariable linear regression. 
Statistical interactions between diabetes status and BP variables were assessed by testing the statistical 
significance of the coefficient of a product term after adjusting for age, BMI, sex, and mean daytime 
SBP (diabetes status × BP variable). A p value of <0.05 was considered statistically significant. All 
data were analysed using Stata 12.1 (StataCorp, College Station, TX, USA). 
Results
Participants with T2DM were older, had higher BMI, and most were on antihypertensive therapy or 
treatment with statins in comparison with non-diabetic participants (Supplementary Table 1). The 24-
h ambulatory mean BP and BPV indices were similar between the groups (Supplementary Table 1) 
and there were no differences in arteriolar diameters [non-diabetics; 25.54(2.74) pixels vs T2DM; 
25.58(2.71) pixels, p = 0.96]. 
In univariate regression analysis, arteriolar diameter was associated positively with daytime rate of 
SBP variation among participants with T2DM (β = 0.007; p = 0.04; R2 = 0.12) and negatively among 
non-diabetics (β = −0.010; p = 0.008; R2 = 0.17). Additionally, mean daytime SBP was negatively 
associated with arteriolar diameter among participants with T2DM (β = −0.003; p = 0.03, R2 = 0.16) 
but not among non-diabetics (β = 0.0003; p  = 0.80). A significant interaction between diabetes status 
and daytime rate of SBP variation was observed and remained significant after adjusting for age, sex, 
BMI, and mean daytime SBP (β = 0.02; p = 0.001; Figure 1). Similar associations were observed when 
BPV was quantified as the CV (interaction p = 0.038). 
Figure 1. Scatter plots and fitted regression lines of the relationship between arteriolar diameter and 
daytime rate of systolic BP variation among non-diabetics and participants with T2DM. 
Discussion
The main finding of this study was that there were significantly different associations between retinal 
arteriolar diameter and BPV indices among healthy individuals and participants with T2DM. Retinal 
arteriolar diameter was positively associated with daytime SBP variation among participants with 
T2DM but negatively among non-diabetic individuals. 
These findings may suggest different pathophysiological contributions of BPV to adverse retinal 
arteriolar outcomes among people with T2DM compared with non-diabetic controls. 
BPV could play a role in large artery damage and remodelling over and above mean BP levels; 
however, despite its importance in cardiovascular disease and stroke in particular,8 the role of BPV in 
microvascular disease is still unclear. This is the first study to assess the relationship between BPV 
and retinal arteriolar diameter and the impact of T2DM on that relationship. 
Our findings of a positive relationship between BPV and retinal arteriolar diameter in participants with 
T2DM could be relevant to the mechanism or consequences of increased BPV. Arteriolar dilatation in 
association with higher BPV in T2DM could be an early sign of impaired vascular autoregulation5 or 
early autonomic neuropathy.10 Both are associated with increased risk of retinal microvascular damage 
that could result from exaggerated fluctuation in transmitted pressure or flow to the microcirculation. 
However, these results should be seen in the context of the limitations of this study; the small sample 
size and the cross-sectional design which limit the interpretation of the findings. 
In conclusion, the findings suggest that increased BP fluctuations may be associated with different 
arteriolar responses in comparison with elevated mean BP levels, with BPV possibly playing a role in 
the pathophysiology of retinal microvasculature in T2DM. Although the mechanisms underlying the 
relationship between BPV and retinal arteriolar in T2DM remain unclear, our findings support the 
need for further investigation. 
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